Seventy-two percent of 129 shigella isolates from two Hong Kong hospitals were Shigellaflexneri. Twenty-six percent were S. sonnei, and there was only one isolate each of S. dysenteriae and S. boydii. Ninety-six percent of the isolates were resistant to two or more antibiotics, and up to 11 resistances were seen in a single isolate. Fifty-seven percent or more of these isolates were resistant to ampicillin, streptomycin, tetracycline, chloramphenicol, and sulfamethoxazole; and up to twenty-three percent were resistant to kanamycin, trimethoprim, trimethoprim-sulfamethoxazole, and gentamicin. All the isolates were susceptible to amikacin, nalidixic acid, and the newer 4-quinolone agents; and all but one were susceptible to the cephalosporins tested. Only three isolates remained resistant to ampicillin in the presence of sulbactam. Ampicillin plus sulbactam or the newer 4-quinolone agents may be alternatives for the treatment of severe infections caused by multiply resistant shigellas.
The incidence of Shigella species resistant to ampicillin, tetracycline, chloramphenicol, and trimethoprim has increased considerably in many parts of the world (10, 13 Ninety-five percent of S. flexneri isolates, all of the S. sonnei isolates, and both S. dysenteriae and S. boydii isolates were resistant to two or more antibiotics. Forty percent of isolates were resistant to four drugs, fourteen percent were resistant to five drugs, and nine percent were resistant to eight drugs ( Table 2 ). The most frequent resistance patterns in S. flexneri isolates were ampicillin, streptomycin, tetracycline, and chloramphenicol; streptomycin, tetracycline, chloramphenicol, and sulfamethoxazole; and ampicillin, streptomycin, tetracycline, chloramphenicol, and sulfamethoxazole. In S. sonnei isolates, the most frequent patterns were streptomycin, tetracycline, and sulfamethoxazole; and ampicillin, streptomycin, tetracycline, chloramphenicol, kanamycin, sulfamethoxazole, trimethoprim, trimethoprim-sulfamethoxazole, and gentamicin. A single isolate of S. flexneri was resistant to 11 agents, including a broad-spectrum cephalosporin and the combination of ampicillin with sulbactam. DISCUSSION Most of our shigella isolates were S. flexneri. A small proportion were S. sonnei, while S. dysenteriae and S. boydii were very uncommon. This distribution is similar to that seen in Bangladesh (15), India (12, 17) , and Korea (3, 26) ; but in the United Kingdom, Western Europe, and the United States, S. sonnei still predominates (6, 22) .
Antimicrobial resistance and multiple resistance were common in these Hong Kong isolates. A large proportion of isolates were resistant to ampicillin, but most of them reverted to susceptibility in the presence of sulbactam, indicating that P-lactamase was responsible for the ampicillin resistance. Ampicillin has been generally accepted as the drug of choice for the treatment of severe bacillary dysentery caused by susceptible organisms (8, 11, 14) . The combination of sulbactam with ampicillin may be an effective alternative in areas where ampicillin-resistant shigella isolates now predominate, but no clinical studies of this combination have been reported.
The incidence of trimethoprim-and trimethoprim-sulfamethoxazole-resistant shigella isolates in Hong Kong is high but is lower than that found in neighboring countries (3, 17, , T  3  2  T, C  1  T, SU  2 (23) .
In Hong Kong, as elsewhere in East Asia, shigella isolates are now frequently multiply resistant to common therapeutic agents, such as ampicillin, sulfamethoxazole, and trimethoprim. However, they remain susceptible to nalidixic acid, the new 4-quinolones, and the combination of ampicillin with sulbactam.
